TERN — Terns Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule
Brief: Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Brief: Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4)
Brief: Terns Announces Pricing Of Upsized $650 Million Public Offering At $40 Per Share
Brief: Terns Announces Proposed Public Offering
U.S. RESEARCH ROUNDUP-AstraZeneca, Confluent, Pepsico
Brief: Terns Pharmaceuticals Says Safety Profile Maintained With Longer Treatment Duration
NASDAQ TRADE HALT HALT NEWS PENDING AT 02:40 PM
U.S. RESEARCH ROUNDUP- Amgen, Crowdstrike, Micron Technology
Terns Pharmaceuticals posts narrower than expected Q3 net loss
Brief: Terns Pharmaceuticals Q3 Net Income USD -24.635 Million Vs. IBES Estimate USD -27.2 Million
U.S. STOCKS ON THE MOVE-Eli Lilly, Palantir, Tesla
Terns soars as early data shows strong response in tough-to-treat leukemia
U.S. STOCKS ON THE MOVE-Mattel, Alphabet, GE Vernova
U.S. STOCKS ON THE MOVE-Healthcare Services Group, Western Alliance, Warner Bros Discovery
Terns Pharma slips after scrapping obesity drug development
U.S. STOCKS ON THE MOVE- Avadel Pharma, Amphenol, Applied Digital
U.S. STOCKS ON THE MOVE-Alphabet, Intuitive Surgical, Thermo Fisher
Terns Pharma down after scrapping obesity drug development following trial failure